Some bloating, pelvic discomfort, injection-site soreness or light spotting may occur during an IVF cycle. However, rapidly worsening abdominal swelling, severe pain, repeated vomiting, reduced urination, breathing difficulty, chest pain, fever or heavy vaginal bleeding are IVF treatment warning signs that need prompt medical assessment.
These symptoms do not automatically mean that a serious complication has occurred. They do mean that your fertility team should evaluate what is happening rather than asking you to monitor the problem alone. This guide explains expected IVF symptoms, possible complications such as ovarian hyperstimulation syndrome and when to call your fertility doctor or seek emergency care.
Medical safety note: This article provides general education and cannot assess your individual symptoms. Follow the instructions given by your own fertility team. Do not stop, increase or change prescribed IVF medication unless a qualified clinician instructs you to do so.
Content prepared: July 29, 2026
Clinical review status: Reviewed by IVF Specialist
Seek prompt medical advice if a symptom is severe, worsening quickly, preventing you from drinking or urinating normally, or accompanied by breathing difficulty, chest pain, fever or heavy bleeding.
Important warning signs include:
OHSS can range from mild discomfort to a serious condition involving fluid accumulation, dehydration, reduced urination, breathing problems and an increased risk of blood clots. The Royal College of Obstetricians and Gynaecologists advises contacting the fertility unit when OHSS symptoms develop.
Do not rely on an online article to determine the severity of these symptoms. When severe symptoms are present, contact your fertility team immediately or attend an appropriate emergency facility if the clinic cannot be reached.
IVF involves several stages, and the symptoms may change as treatment progresses. The step-by-step IVF process commonly includes ovarian stimulation, monitoring, egg retrieval, fertilization, embryo culture, embryo transfer and pregnancy testing.
Mild symptoms that may occur include:
The HFEA notes that patients may feel sore or bruised following egg collection. RCOG guidance also explains that mild abdominal swelling, discomfort and nausea can occur with mild OHSS.
The presence of a mild symptom does not automatically make it “normal” for every person. What matters is its intensity, duration, progression and relationship to other symptoms.
For example:
When you are uncertain, contacting the fertility clinic is appropriate. You are not expected to diagnose a complication by yourself.
The following framework can help you decide what type of response may be appropriate. Your clinic’s individual instructions take priority.
| Symptom | Often monitored when mild and improving | Contact the fertility clinic promptly | Seek urgent or emergency assessment |
| Abdominal bloating | Mild fullness or swelling | Bloating that is clearly worsening or interfering with movement or eating | Rapid swelling with breathing difficulty, severe pain, vomiting or reduced urination |
| Pelvic pain | Mild cramps or soreness | Persistent or increasing pain | Sudden, severe or one-sided pain, especially with vomiting or bleeding |
| Nausea | Mild and able to eat and drink | Persistent nausea or reduced fluid intake | Repeated vomiting or inability to keep fluids down |
| Urination | Normal amount and colour | Less urine than expected or darker urine | Very little urine with severe swelling, dizziness or breathing difficulty |
| Vaginal bleeding | Light spotting | Bleeding that continues, increases or causes concern | Heavy bleeding, severe pain, weakness or faintness |
| Breathing | Normal | New mild breathlessness | Significant shortness of breath, chest pain or inability to speak comfortably |
| Temperature and discharge | No fever; normal discharge | New unpleasant-smelling discharge or feeling unwell | Fever, chills, severe pain or marked illness |
| Leg symptoms | No unusual swelling | New leg discomfort | One swollen, red or tender leg, especially with chest pain or breathlessness |
This table is not a diagnostic tool. Symptoms can overlap between OHSS, infection, bleeding, pregnancy-related complications and unrelated illnesses. Clinical assessment may involve questions about your medication, timing, urine output, weight changes, blood tests, ultrasound or physical examination.
Ovarian hyperstimulation syndrome, or OHSS, is a potential complication of fertility treatment in which the ovaries respond excessively to ovarian-stimulation medication.
During stimulation, medication encourages multiple ovarian follicles to develop. In OHSS, enlarged ovaries and chemical changes can cause fluid to move out of blood vessels and collect in the abdomen. More severe disease can affect hydration, kidney function, breathing and blood-clot risk.
RCOG patient guidance states that mild OHSS may affect up to approximately one-third of women undergoing IVF, while just over one in 100 may develop moderate or severe OHSS. Rates can vary depending on patient characteristics, treatment protocols and the way severity is defined.
Most IVF patients do not develop severe OHSS. Modern monitoring and individualized protocols are intended to identify high ovarian response and reduce risk. Nevertheless, patients need clear instructions because symptoms can sometimes progress after egg retrieval or embryo transfer.
Possible OHSS symptoms include:
Severe OHSS may also be associated with chest pain or symptoms of a blood clot, such as a swollen and tender leg. RCOG advises reporting unusual symptoms to the treating doctor.
OHSS often becomes noticeable after the final trigger injection and egg collection. It may develop or worsen after embryo transfer, particularly if pregnancy occurs because pregnancy hormones can continue stimulating the ovaries.
An NHS fertility resource notes that symptoms may initially improve and then worsen again closer to the pregnancy-test date. Another NHS resource explains that later OHSS can appear after implantation and the production of pregnancy hormones.
This means that patients should continue monitoring symptoms even after the egg-retrieval procedure has finished.
Contact the fertility clinic promptly when you notice:
Seek urgent assessment for:
Do not try to classify your own OHSS as mild, moderate or severe based only on a checklist. A clinician may need to assess hydration, vital signs, abdominal swelling, ovarian size, blood concentration, kidney function and fluid accumulation.
Mild abdominal fullness may occur as the ovaries respond to medication and follicles grow. Some mild bloating may also occur after egg retrieval.
The safer question is not only “How bloated am I?” but also:
Mild bloating that remains stable and improves can often be monitored according to the clinic’s instructions. Bloating that progresses, particularly with vomiting, dark urine, reduced urination or breathing difficulty, needs medical assessment because these symptoms may be related to OHSS.
Avoid relying on weight or abdominal measurements alone. Changes are more useful when considered together with symptoms and your clinical history.
Light spotting can occur after embryo transfer and does not reliably indicate whether implantation has succeeded or failed. An NHS fertility service states that light bleeding and spotting after embryo transfer are common and that pregnancy can only be determined through the scheduled test.
Bleeding deserves prompt medical advice when it is:
Heavy or irregular vaginal bleeding, fever, abdominal pain and feeling unwell can occur with complications following egg retrieval and should be reported promptly.
Bleeding before the scheduled pregnancy-test date does not prove that IVF has failed. One NHS assisted-conception service specifically advises patients to perform the scheduled pregnancy test even if bleeding occurs, because bleeding can also occur with an ectopic pregnancy.
Continue prescribed medication unless your treating clinician advises otherwise. Stopping progesterone or another medicine based only on bleeding could interfere with the treatment plan.
Mild cramping, pelvic pressure or soreness may occur during stimulation, after egg retrieval or around embryo transfer. Pain should generally remain manageable and improve rather than intensify.
Contact your fertility clinic when pain:
Sudden, severe or strongly one-sided abdominal pain requires urgent assessment. IVF patients can develop conditions other than OHSS, and symptoms should not automatically be attributed to medication.
After embryo transfer, one-sided lower abdominal pain with vaginal bleeding or dark discharge may be a symptom of ectopic pregnancy. An ectopic pregnancy occurs when a pregnancy implants outside the uterus and requires medical assessment.
Shortness of breath can occur with severe OHSS if fluid accumulates in or around the chest. Chest pain and breathlessness can also be signs of a blood clot affecting the lungs.
RCOG lists difficulty breathing, chest pain and a swollen, tender leg among serious symptoms requiring medical attention.
Do not wait for routine clinic hours when breathing is significantly difficult or chest pain is present. Seek urgent medical assessment.
Dark, concentrated urine or passing much less urine than expected can indicate dehydration or fluid-balance problems associated with OHSS.
This warning sign is particularly important when combined with worsening abdominal swelling, vomiting, thirst or breathlessness.
One isolated episode of nausea is different from repeated vomiting. Vomiting becomes concerning when you cannot keep fluids down, your urine output decreases or other OHSS symptoms are worsening.
Persistent vomiting can contribute to dehydration and requires advice from the fertility clinic.
Pelvic infection after egg retrieval is uncommon, but it is possible. Warning signs may include:
An NHS assisted-conception guide advises prompt assessment when these symptoms occur following egg collection.
A new swollen, red, tender or painful leg can be a sign of a blood clot. This is particularly urgent when accompanied by chest pain or shortness of breath.
Severe OHSS can increase blood-clot risk because of changes in fluid balance and blood concentration.
You should call your fertility doctor whenever a symptom is worsening, unusual for you or making you concerned. You do not have to wait until every warning sign is present.
Use this three-level decision framework.
Monitoring may be reasonable when symptoms are:
Continue keeping your clinic informed as instructed.
Call the fertility team when:
When calling, be prepared to explain:
Urgent assessment is appropriate for:
When attending another hospital, tell the medical team that you are undergoing fertility treatment. Provide the clinic name, medication list, trigger-injection date, egg-retrieval date and embryo-transfer date when available.
No. Symptoms alone cannot confirm whether IVF has resulted in pregnancy.
Breast tenderness, fatigue, bloating, nausea and cramping may be related to progesterone or other treatment medication. Some people who become pregnant experience few symptoms, while others experience symptoms before the pregnancy test.
Similarly, spotting or a temporary reduction in symptoms does not prove that IVF has failed. The HFEA advises patients not to test earlier than the date given by the clinic because an early result can be inaccurate.
Follow the clinic’s testing schedule. Depending on the protocol, pregnancy may be checked with a urine test or beta-hCG blood test. Further blood testing and ultrasound may be needed before confirming the location and development of a pregnancy.
For guidance on preparation and treatment planning, review what to expect during your first IVF consultation.
No. IVF does not automatically mean that every pregnancy will be high risk.
Risk depends on several factors, including:
The HFEA states that fertility treatment is generally safe and that the overall individual risk of pregnancy complications remains low, although some risks can be slightly increased. Multiple pregnancy is an important factor because twins and higher-order pregnancies have greater obstetric risks than singleton pregnancies.
Your fertility specialist and obstetric team should assess your individual risk rather than treating every IVF pregnancy as identical.
Patients travelling to Kathmandu from other districts may need repeated monitoring, procedures and follow-up. Before beginning treatment, create a written safety plan.
Keep the following information accessible:
The Slavica IVF is located at Sinamangal, Kathmandu, with regular opening hours from Sunday to Friday. Patients should confirm the current emergency-contact process directly with the clinic because website hours do not necessarily describe after-hours clinical support.
Before leaving Kathmandu, ask:
Some patients can travel safely during portions of treatment, while others may need to remain close to the fertility centre because of ovarian response, egg retrieval, embryo transfer or OHSS risk.
Travel decisions should be individualized. Do not assume that feeling well on one day means that symptoms cannot develop later.
Do not stop progesterone, injections or other prescribed medication because of spotting, cramping, nausea or an early home-pregnancy-test result. Contact the treating team before making changes.
A good IVF patient guide should include communication planning, not only medication instructions.
Ask your clinic:
Slavica IVF provides a published overview of its IVF treatment service and introduces IVF specialist Dr. Nikita Dhakal on its official website. Prospective patients should use a consultation to discuss personal risks, alternatives and emergency communication before starting treatment.
There are no physical symptoms that can reliably confirm successful IVF. Mild cramping, breast tenderness, tiredness, bloating, nausea or spotting may occur, but these can also be caused by progesterone and other fertility medications. The scheduled pregnancy test is the appropriate way to determine the initial result, followed by further testing or ultrasound when required.
A failed IVF cycle cannot be diagnosed from symptoms alone. Bleeding, reduced breast tenderness or the absence of pregnancy symptoms may occur, but none is definitive. Take the pregnancy test on the date provided by the fertility clinic, even when bleeding happens before that date, and do not stop medication without clinical advice.
IVF does not automatically make every patient or pregnancy high risk. Individual risk depends on age, medical history, the cause of infertility, ovarian response, treatment protocol and whether a multiple pregnancy occurs. Fertility treatment is generally safe, although OHSS, ectopic pregnancy and some pregnancy complications require appropriate counselling and monitoring.
Possible IVF treatment symptoms include mild bloating, pelvic pressure, temporary nausea, injection-site soreness, breast tenderness, mild cramps and soreness after egg retrieval. Light spotting may occur after embryo transfer. Severe pain, rapidly increasing swelling, repeated vomiting, reduced urination, breathing difficulty, fever or heavy bleeding are not symptoms to ignore.
Yes. OHSS may begin or worsen after egg retrieval or embryo transfer. If pregnancy occurs, pregnancy hormones can prolong or intensify the condition. Continue monitoring for worsening bloating, vomiting, dark or reduced urine, breathing difficulty and rapid symptom progression after the procedure.
Light spotting can occur after embryo transfer and does not necessarily indicate treatment failure. However, bleeding that becomes heavy, continues to increase or occurs with severe pain, weakness, fever or abnormal discharge needs medical assessment. Continue medication and follow the clinic’s pregnancy-testing instructions unless your clinician advises otherwise.
Severe or rapidly worsening bloating should be assessed promptly, especially when accompanied by pain, vomiting, reduced urination, dark urine or breathing difficulty. These symptoms may indicate moderate or severe OHSS. Contact your fertility team immediately and seek urgent care when symptoms are severe or the clinic cannot be reached.
